ARCHIVES

Volasertib Shows Response In 31 Percent of Acute Myeloid Leukemia Patients

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

FDA Approves Silicone Gel Breast Implants, Requires 10 Years Of Patient Follow-Up

November 24, 2006

No Site Visit For Georgetown Lombardi as Federal Government Shuts Down

October 4, 2013

Formal Guidelines For Training Grants Developed By NCI

December 7, 1979

Suitable Mechanism, Funding Source Were Issues In diet FIT

December 15, 1989

Funding Opporunities: Program Announcments

January 15, 1999

DCT Board reluctantly Okays Resources Contracts Recompetition, $6 of $10 Million Competitively

April 1, 1977